Based on 1 analyst offering 12 month price targets for Profound Medical Corp
Min Forecast
$12.00+101.68%
Avg Forecast
$12.00+101.68%
Max Forecast
$12.00+101.68%
Should I buy or sell PROF stock?
Based on 1 analyst offering ratings for Profound Medical Corp.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PROF's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates PROF as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their PROF stock forecasts and price targets.
Is Profound Medical Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: PROF) stock is to Strong Buy PROF stock.
Out of 1 analyst, 1 (100%) are recommending PROF as a Strong Buy, 0 (0%) are recommending PROF as a Buy, 0 (0%) are recommending PROF as a Hold, 0 (0%) are recommending PROF as a Sell, and 0 (0%) are recommending PROF as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year PROF price target, the average PROF price target is $12.00, with the highest PROF stock price forecast at $12.00 and the lowest PROF stock price forecast at $12.00.
The Wall Street analyst predicted that Profound Medical's share price could reach $12.00 by Jan 7, 2027. The average Profound Medical stock price prediction forecasts a potential upside of 101.68% from the current PROF share price of $5.95.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.